News

A first-in-kind immune-modulating drug that arose from decades of basic research has received approval as a new treatment for adults with a form of myasthenia gravis.

Researchers have discovered that diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick the cancer cells into starving themselves.

Research reveals that T cells, one of the body’s key defenses against SARS-CoV-2, are expected to be effective in mounting an immune response against Omicron despite a significant number of mutations.

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.

An olfactory receptor typically associated with the sense of smell may also trigger breast cancer cells to metastasize through a signaling pathway to the brain, bones and lung.

Researchers have used state-of-the-art experimental and computational tools to reveal the mechanism of action and substrate specificity of lipoprotein-associated phospholipase A2, a biomarker for cardiovascular disease.

Carbon dioxide can be harvested from smokestacks and used to create commercially valuable chemicals thanks to a novel compound that has been developed.

Researchers have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest that tests with the new assay may be just as reliable as the laboratory-based molecular tests used by hospitals for clinical diagnostics.

Scientists have identified a new Achilles’ heel of influenza virus, making progress in the quest for a universal flu vaccine.

New research is continuing to uncover details about how a diet that includes too much red meat can impact our risk of heart disease, including heart attack and stroke. And it’s not just about fats and cholesterol.